Abstract:The glutamate transporter GLT‐1 is predominantly expressed in astrocytes. In neurons, GLT‐1 is expressed mainly in axon terminals. Conditional knockout of the gene expressing GLT‐1 in neurons prevents recovery of hippocampal synaptic function by increased vulnerability to excitotoxic injury. Hippocampal slices from these mutant mice have multiple neuronal and astrocytic abnormalities of glucose metabolism, including reduced glucose oxidation, decreased phosphorylation of pyruvate dehydrogenase, and delayed replenishment of glycogen stores. Targeting mitochondrial superoxide production prevents excitotoxic injury and restores synaptic function. Excitotoxicity thus appears to be finely controlled by mitochondrial superoxide homeostasis tightly linked to the metabolic functions of neuronal GLT‐1. We have previously reported a failure of recovery of synaptic function in the CA1 region of acute hippocampal slices from mice with a conditional neuronal knockout (KO) of GLT‐1 (EAAT2, Slc1A2) driven by synapsin‐Cre (synGLT‐1 KO). The failure of recovery of synaptic function is due to excitotoxic injury. We hypothesized that changes in mitochondrial metabolism contribute to the heightened vulnerability to excitotoxicity in the synGLT‐1 KO mice. We found impaired flux of carbon from 13C‐glucose into the tricarboxylic acid cycle in synGLT‐1 KO cortical and hippocampal slices compared with wild‐type (WT) slices. In addition, we found downregulation of the neuronal glucose transporter GLUT3 in both genotypes. Flux of carbon from [1,2‐13C]acetate, thought to be astrocyte‐specific, was increased in the synGLT‐KO hippocampal slices but not cortical slices. Glycogen stores, predominantly localized to astrocytes, are rapidly depleted in slices after cutting, and are replenished during ex vivo incubation. In the synGLT‐1 KO, replenishment of glycogen stores during ex vivo incubation was compromised. These results suggest both neuronal and astrocytic metabolic perturbations in the synGLT‐1 KO slices. Supplementing incubation medium during recovery with 20 mM D‐glucose normalized glycogen replenishment but had no effect on recovery of synaptic function. In contrast, 20 mM non‐metabolizable L‐glucose substantially improved recovery of synaptic function, suggesting that D‐glucose metabolism contributes to the excitotoxic injury in the synGLT‐1 KO slices. L‐lactate substitution for D‐glucose did not promote recovery of synaptic function, implicating mitochondrial metabolism. Consistent with this hypothesis, phosphorylation of pyruvate dehydrogenase, which decreases enzyme activity, was increased in WT slices during the recovery period, but not in synGLT‐1 KO slices. Since metabolism of glucose by the mitochondrial electron transport chain is associated with superoxide production, we tested the effect of drugs that scavenge and prevent superoxide production. The superoxide dismutase/catalase mimic EUK‐134 conferred complete protection and full recovery of synaptic function. A site‐specific inhibitor of complex III superoxide production, S3QEL‐2, was also protective, but inhibitors of NADPH oxidase were not. In summary, we find that the failure of recovery of synaptic function in hippocampal slices from the synGLT‐1 KO mouse, previously shown to be due to excitotoxic injury, is caused by production of superoxide by mitochondrial metabolism.

Isolation of the murine Glut1 deficient thalamocortical circuit: wavelet characterization and reverse glucose dependence of low and gamma frequency oscillations

Metabolic modulation of synaptic failure and thalamocortical hypersynchronization with preserved consciousness in Glut1 deficiency

Resolution of High-Frequency Mesoscale Intracortical Maps Using the Genetically Encoded Glutamate Sensor iGluSnFR.

Cerebellar output controls generalized spike-and-wave discharge occurrence

Altered Glutamate Metabolism Contributes to Antiepileptogenic Effects in the Progression from Focal Seizure to Generalized Seizure by Low-Frequency Stimulation in the Ventral Hippocampus

Epileptiform activity in brain organoids derived from patient with Glucose Transporter 1 Deficiency Syndrome

Astrocytic GABA Transporter 1 Deficit in Novel SLC6A1 Variants Mediated Epilepsy: Connected from Protein Destabilization to Seizures in Mice and Humans.

Misprogramming of glucose metabolism impairs recovery of hippocampal slices from neuronal GLT‐1 knockout mice and contributes to excitotoxic injury through mitochondrial superoxide production

Transient Seizure Clusters and Epileptiform Activity Following Widespread Bilateral Hippocampal Interneuron Ablation

Seizures regulate the cation-Cl− cotransporter NKCC1 in a hamster model of epilepsy: implications for GABA neurotransmission

Delving into the significance of the His289Tyr single-nucleotide polymorphism in the glutamate ionotropic receptor kainate-1 (Grik1) gene of a genetically audiogenic seizure model

Medial septal GABAergic neurons reduce seizure duration upon optogenetic closed-loop stimulation

Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis

Structural and molecular characterization of paraventricular thalamic glucokinase-expressing neuronal circuits in the mouse

Characterization of kindled VGAT‐Cre mice as a new animal model of temporal lobe epilepsy

Brain Microvasculature Defects and Glut1 Deficiency Syndrome Averted by Early Repletion of the Glucose Transporter-1 Protein

GLUT-1DS resistant to ketogenic diet: from clinical feature to in silico analysis. An exemplificative case report with a literature review

Persistent aberrant cortical phase-amplitude coupling following seizure treatment in absence epilepsy models

Neuronal rhythmicity and cortical arousal in a mouse model of absence epilepsy

In Vivo Mapping of Temporospatial Changes in Glucose Utilization in Rat Brain During Epileptogenesis: an 18F-Fluorodeoxyglucose–small Animal Positron Emission Tomography Study

Synaptic Integration in CA1 Pyramidal Neurons Is Intact despite Deficits in GABAergic Transmission in the Scn1a Haploinsufficiency Mouse Model of Dravet Syndrome